Henry E. Pelish's most recent trade in Nuvalent Inc - Ordinary Shares - Class A was a trade of 41,100 Class A Common Stock - Restricted Stock Units done . Disclosure was reported to the exchange on July 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 41,100 | 0 | - | - | Class A Common Stock - Restricted Stock Units | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 37,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | 15 Jul 2026 | 22,393 | 0 | - | - | Class A Common Stock | ||
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 21,073 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 18,600 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 17,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2026 | 14,350 | 14,350 | - | 0 | Class A Common Stock - Performance Stock Units | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 14,350 | 0 | - | - | Class A Common Stock - Performance Stock Units | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 9,900 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 8,309 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 3,258 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 2,113 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 123.81 per share. | 09 Jul 2026 | 2,111 | 63,493 | - | 123.8 | 261,363 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2026 | 3,093 | 8,309 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 09 Apr 2026 | 3,093 | 68,697 | - | 27.8 | 86,140 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 104.27 per share. | 09 Apr 2026 | 2,193 | 66,504 | - | 104.3 | 228,664 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 105.00 per share. | 09 Apr 2026 | 900 | 65,604 | - | 105 | 94,500 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 97.79 per share. | 12 Mar 2026 | 24,189 | 76,519 | - | 97.8 | 2,365,442 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 12 Mar 2026 | 8,456 | 91,844 | - | 18.9 | 160,072 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 8,456 | 2,113 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 98.44 per share. | 12 Mar 2026 | 5,505 | 71,014 | - | 98.4 | 541,912 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.33 per share. | 12 Mar 2026 | 4,125 | 97,723 | - | 29.3 | 120,986 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 4,125 | 9,900 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.35 per share. | 12 Mar 2026 | 2,985 | 100,708 | - | 72.4 | 215,965 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 2,985 | 21,073 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 98.83 per share. | 12 Mar 2026 | 2,597 | 67,307 | - | 98.8 | 256,662 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 12 Mar 2026 | 1,754 | 93,598 | - | 27.9 | 48,849 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 1,754 | 11,402 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 99.71 per share. | 12 Mar 2026 | 1,703 | 65,604 | - | 99.7 | 169,806 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 97.89 per share. | 12 Mar 2026 | 804 | 69,904 | - | 97.9 | 78,704 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 99.12 per share. | 12 Mar 2026 | 306 | 70,708 | - | 99.1 | 30,331 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 83,388 | - | 0 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 97.33 per share. | 05 Jan 2026 | 1,369 | 66,077 | - | 97.3 | 133,245 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 97.96 per share. | 05 Jan 2026 | 1,137 | 68,738 | - | 98.0 | 111,381 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 96.75 per share. | 05 Jan 2026 | 1,106 | 67,446 | - | 96.8 | 107,006 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 96.85 per share. | 05 Jan 2026 | 660 | 69,875 | - | 96.9 | 63,921 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 96.06 per share. | 05 Jan 2026 | 513 | 70,535 | - | 96.1 | 49,279 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 98.40 per share. | 05 Jan 2026 | 189 | 65,888 | - | 98.4 | 18,598 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 98.52 per share. | 05 Jan 2026 | 186 | 68,552 | - | 98.5 | 18,325 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2025 | 5,085 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 22 Dec 2025 | 5,085 | 71,048 | - | 1.1 | 5,492 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 90.04 per share. | 15 Oct 2025 | 14,205 | 65,963 | - | 90.0 | 1,279,018 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 15 Oct 2025 | 7,495 | 77,126 | - | 27.9 | 208,736 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 7,495 | 13,156 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 3,668 | 10,569 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 15 Oct 2025 | 3,668 | 69,631 | - | 18.9 | 69,435 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 3,042 | 24,058 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.35 per share. | 15 Oct 2025 | 3,042 | 80,168 | - | 72.4 | 220,089 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 89.81 per share. | 13 Oct 2025 | 7,637 | 65,963 | - | 89.8 | 685,879 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2025 | 4,168 | 21,528 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 13 Oct 2025 | 4,168 | 71,800 | - | 27.9 | 116,079 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2025 | 1,800 | 27,100 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.35 per share. | 13 Oct 2025 | 1,800 | 73,600 | - | 72.4 | 130,230 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2025 | 1,669 | 14,968 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 13 Oct 2025 | 1,669 | 67,632 | - | 18.9 | 31,594 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 84.98 per share. | 13 Oct 2025 | 1,167 | 67,229 | - | 85.0 | 99,172 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2025 | 877 | 20,651 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 13 Oct 2025 | 877 | 67,571 | - | 27.8 | 24,424 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 86.11 per share. | 13 Oct 2025 | 866 | 66,363 | - | 86.1 | 74,571 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2025 | 825 | 14,025 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.33 per share. | 13 Oct 2025 | 825 | 68,396 | - | 29.3 | 24,197 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2025 | 731 | 14,237 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 13 Oct 2025 | 731 | 66,694 | - | 18.9 | 13,838 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 87.39 per share. | 13 Oct 2025 | 400 | 65,963 | - | 87.4 | 34,956 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 78.83 per share. | 10 Sep 2025 | 3,725 | 65,963 | - | 78.8 | 293,642 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2025 | 2,117 | 14,850 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.33 per share. | 10 Sep 2025 | 2,117 | 69,688 | - | 29.3 | 62,092 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2025 | 877 | 25,696 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 10 Sep 2025 | 877 | 67,571 | - | 27.8 | 24,424 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 10 Sep 2025 | 731 | 66,694 | - | 18.9 | 13,838 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2025 | 731 | 16,637 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2025 | 3,000 | 5,085 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 29 Aug 2025 | 3,000 | 65,963 | - | 1.1 | 3,240 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2025 | 2,007 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.87 per share. | 29 Aug 2025 | 2,007 | 62,963 | - | 0.9 | 1,746 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 74.85 per share. | 07 Aug 2025 | 5,500 | 60,956 | - | 74.9 | 411,675 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2025 | 3,892 | 16,967 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.33 per share. | 07 Aug 2025 | 3,892 | 66,456 | - | 29.3 | 114,152 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2025 | 877 | 26,573 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 07 Aug 2025 | 877 | 62,564 | - | 27.8 | 24,424 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 07 Aug 2025 | 731 | 61,687 | - | 18.9 | 13,838 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2025 | 731 | 17,368 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 79.94 per share. | 09 Jul 2025 | 5,260 | 61,196 | - | 79.9 | 420,484 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 4,440 | 20,859 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.33 per share. | 09 Jul 2025 | 4,440 | 66,456 | - | 29.3 | 130,225 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 81.08 per share. | 09 Jul 2025 | 1,945 | 61,156 | - | 81.1 | 157,701 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 878 | 27,450 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 09 Jul 2025 | 878 | 62,016 | - | 27.8 | 24,452 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 80.92 per share. | 09 Jul 2025 | 240 | 60,956 | - | 80.9 | 19,421 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 81.90 per share. | 09 Jul 2025 | 200 | 60,956 | - | 81.9 | 16,380 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 182 | 18,099 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 09 Jul 2025 | 182 | 61,138 | - | 18.9 | 3,445 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 79.87 per share. | 25 Jun 2025 | 8,630 | 63,101 | - | 79.9 | 689,278 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.33 per share. | 25 Jun 2025 | 4,953 | 71,731 | - | 29.3 | 145,271 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2025 | 4,953 | 27,122 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 25 Jun 2025 | 3,677 | 66,778 | - | 27.8 | 102,404 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2025 | 3,677 | 28,675 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 79.92 per share. | 25 Jun 2025 | 2,170 | 63,101 | - | 79.9 | 173,426 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.33 per share. | 25 Jun 2025 | 1,823 | 65,271 | - | 29.3 | 53,469 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2025 | 1,823 | 25,299 | - | - | Stock Option (Right to Buy) |